Larvol Delta - Axalbion-to-Present-Promising-Phase-2-Clinical-Data-in-Chronic-Cough-with-AX8-a-Novel-TRPM8-Agonist-in-an-Oral-Presentation-at-the-American-Thoracic-Society-ATS-2023-International-Conference

AX-8 - Axalbion

https://www.globenewswire.com/news-release/2023/03/21/2631288/0/en/Cerevance-Announces-Presentations-at-Two-Medicinal-Chemistry-Conferences.html

Mar 21, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next